Levin, Ellis R. Invited Review: Cell localization, physiology, and nongenomic actions of estrogen receptors. J Appl Physiol 91: [1860][1861][1862][1863][1864][1865][1866][1867] 2001.-The existence of binding proteins for the female sex steroid, 17␤-estradiol, has been known for almost 50 years. Presently, two estrogen receptors (ERs), ER-␣ and ER-␤, have been cloned in mammals, and they are expressed in many cell types of metazoans. ERs act primarily as nuclear transcription factors, and this effect is enhanced by ligand binding. Emerging data have identified a separate pool of receptors for this steroid in the plasma membrane, but the mechanisms of action and cellular functions of these proteins are just beginning to be defined. In this review, the known details of the nuclear and plasma membrane ER functions will be discussed. A particular focus will be to define the signaling pathways from the membrane that lead to important cell physiology effects of estrogen. The potential interactions of membrane ER with other local proteins will also be discussed, and the unique but often complementary roles of the receptor pools will be highlighted. These details may be of additional relevance to other steroid receptors, since there is evidence of their existence in the cell membrane. nuclear receptors; apoptosis; membrane receptors; steroid receptors; signal transduction; cell proliferation ESTROGEN RECEPTORS (ERs) mediate the important actions of the endogenous steroid hormone, 17␤-estradiol (E 2 ), and thereby participate in various aspects of cellular physiology. ER is synthesized in many cell types as two protein forms, ER-␣ (19, 20) and ER-␤ (30, 48, 79), which are the products of separate genes. Alternatively spliced transcripts for the receptors largely account for the differential length binding proteins in discrete cell types. In many cells, the receptors coexist either as homodimers or as heterodimers (11, 55) , but the distribution of the two receptors does not completely overlap. ER-␣ exists as the predominant receptor in most target organs (38). However, ER-␤ is prominently expressed in ovary, prostate, lung, and hypothalamus (9, 31), and recent evidence indicates that there are specific actions of E 2 that can be attributed to one receptor but not the other (30, 70, 81) . The actions of E 2 occur on binding ER, and at least the nuclear pool of these receptors then transactivates relevant genes (17, 21) . In some circumstances, the ER subtypes differentially transactivate target genes that participate in the cell biological effects of the steroid hormone (52, 76, and reviewed in Refs. 50 and 67).
ESTROGEN RECEPTORS (ERs) mediate the important actions of the endogenous steroid hormone, 17␤-estradiol (E 2 ), and thereby participate in various aspects of cellular physiology. ER is synthesized in many cell types as two protein forms, ER-␣ (19, 20) and ER-␤ (30, 48, 79) , which are the products of separate genes. Alternatively spliced transcripts for the receptors largely account for the differential length binding proteins in discrete cell types. In many cells, the receptors coexist either as homodimers or as heterodimers (11, 55) , but the distribution of the two receptors does not completely overlap. ER-␣ exists as the predominant receptor in most target organs (38) . However, ER-␤ is prominently expressed in ovary, prostate, lung, and hypothalamus (9, 31) , and recent evidence indicates that there are specific actions of E 2 that can be attributed to one receptor but not the other (30, 70, 81) . The actions of E 2 occur on binding ER, and at least the nuclear pool of these receptors then transactivates relevant genes (17, 21) . In some circumstances, the ER subtypes differentially transactivate target genes that participate in the cell biological effects of the steroid hormone (52, 76 , and reviewed in Refs. 50 and 67) .
Gene deletion of each of the two receptor proteins has revealed the importance of E 2 for normal female sex organ development and function (10, 30, 38) . Both in vivo and in vitro studies in mammals have suggested that E 2 has significant actions for the preservation of bone (74) and blood vessel integrity (44, 71) and contributes to brain function (42) and the modulation of immunity (86) . Estrogen also appears to be a significant growth and survival factor for human breast cancer cells (45, 64) . Several of the actions of estrogen (as well as other steroid hormones) occur rapidly and are therefore considered to be nongenomic (reviewed in Ref. 35) . These effects include the enactment of signal transduction originating from the plasma membrane.
Insight into the rapid, nongenomic actions of E 2 began to take substance more than 20 years ago when a second pool of ERs was identified (57, 58) . Subsequent work has begun to clarify the location and function of this binding protein in the cell plasma membrane (7, 8, 63, 68) . The membrane receptor(s) has not been isolated or sequenced to date, but there appears to be ER-␣ that is structurally very similar to the nuclear receptor in many cell types (53) . The membrane ERs probably also include ER-␤ (63). Various signal transduction pathways have been recently identified to be rapidly triggered by E 2 , and these contribute to the cell biological effects of this steroid.
NUCLEAR RECEPTORS
The identification of receptors for E 2 was most advanced by work from the laboratories of Jensen and Gorski (4, 23, 78) . Subsequent purification of the binding protein (now known as ER-␣) resulted in antibodies being generated (19) , and this led to the localization of receptors in the nucleus of target cells for E 2 action (28) . The cDNA for the human ER-␣ was cloned in 1985 (82) ; in the 1990s, evidence of complex interactions with coactivator proteins and basal transcriptional machinery proteins was provided (reviewed in Ref. 40) (Fig. 1 ).
An important discovery of a second ER, ER-␤, was reported in 1996 (32, 48, 79) . ER-␣ and ER-␤ are individually well conserved through mammalian species (54, 79) , and there is evidence of a newly identified receptor, ER-␥, in teleost fish (22) . The two nuclear receptors are homologous mainly in their DNA binding and ligand pocket binding domains but less so in their respective hinge and ligand-independent activation function (AF-1) region. Alternative splicing of the mRNA of ER-␤ gives rise to several protein isoforms, and a recently described 46-kDa ER-␣ isoform may be important in breast cancer (17) .
The steroid receptor translocates to the nuclear membrane from the cytosol in a ligand-independent fashion (54) and can activate transcription independently of ligand. However, ligand serves to recruit coactivator proteins (and leads to the displacement of corepressors), functioning mainly through the AF-2 domain of the receptors. The transcriptional effects of the nuclear receptors can be mediated through several mechanisms. E 2 -ER complexes bind classical inverse palindromic (CAGGTCAnnnTGACCTGA) or nonclassical estrogen response elements on the promoters of target genes. Alternatively, E 2 -ER complexes transactivate genes through protein-protein interactions with 1) transcription factors such as activator protein 1 or Sp-1 that bind DNA, 2) coaccessory proteins (Src, ACTR), some of which have histone acetylase activity, and 3) RNA polymerase II complex proteins (43) . There is evidence that ligation of the two nuclear receptors can differentially transactivate genes (52) and, as mentioned, that the receptors can form heterodimers in vivo (11, 55) . In addition, ERs serve to repress genes (80) , and this also plays important roles in E 2 action.
Traditionally, many of the functions of E 2 are proposed to be mediated through target gene upregulation, considered to be the main function of the nuclear ER (reviewed in Ref. 10) . This is most apparent in sex organ development and function in females. ER-␣ also has an important but unanticipated role in fertility and sperm maturation and function, as demonstrated in the ER-␣ knockout male mouse (14) . Estrogen also affects central nervous system functions and the neuroendocrine-gonadal axis in both sexes and seems to preserve bone density (10) . Thus the loss of estrogen action after menopause is considered a major risk factor in the development of osteoporosis in women (reviewed in Ref. 62 ). There is also epidemiological and experimental data supporting the importance of estrogen to prevent atherosclerosis (44, 75) and to affect immunity (41, 86) . Estrogen promotes breast cancer propagation (69) and mediates complex sexual behaviors, at least in rodents (56) . In some of these situations, the genes that serve as targets for transactivation by the nuclear ER and participate in estrogeninduced cell biology have been identified. However, in many instances, the important target genes are unknown. Another caveat is the recent identification of membrane ER (see below). Because E 2 can induce rapid signaling from the membrane, it is likely that the cell biology of estrogen action is more complex than originally anticipated by invoking the nuclear model. Determining the relative contributions by each of these two receptor pools is an important focus in understanding the overall actions of the sex steroid.
MEMBRANE RECEPTORS
Background. Pietras and Szego (57, 58) originally described an E 2 -binding protein in cell membranes that triggered the rapid generation of cAMP. Subsequent work from many investigators indicated that E 2 rapidly activates signaling, such as calcium flux (77), phospholipase C activation (34) , and inositol trisphosphate (IP 3 ) generation (36) . In most studies, these actions appear to require E 2 binding to ERs. In neural cells, ERs can activate protein kinase C and protein kinase A and uncouple opioidergic and gabanergic receptors from their effector signaling molecules (reviewed in Ref. 27 ). These signaling events are likely to arise from the activation of G proteins by E 2 , and this was directly shown for G s ␣ and G q ␣ in Chinese hamster ovary (CHO) cells expressing either subtype of ER (63) . Thus ERs appear to be part of the large family of G-protein-coupled receptors (GPCR). After several G proteins are activated, E 2 -ER can then trigger signaling cascades that culminate in a cell biological function.
Signaling pathways activated by estrogen and implications for cell physiology. An important pathway for E 2 action is the stimulation of the proline-directed, threonine/serine kinase, extracellular-regulated kinase (ERK). This member of the mitogen-activated protein (MAP) kinase family is rapidly (5 min) activated by E 2 and results from more proximal kinase activation, including Ras, Src, raf, and MAP kinase kinase stimulation in MCF-7 breast cancer cells (45) . ERK activation via this cascade contributes to E 2 -induced proliferation (6) and survival of MCF-7 cells (64) and prostate cancer cell proliferation (46) , whereas specific ER antagonists such as ICI-182780 inhibit E 2 activation of this (and many) signals. Recently, Kousteni et al. (29) showed that E 2 signaled through the same pathway, to the survival of osteoblasts. Interestingly, osteoblast survival could also be shown in HeLa cells, mediated by targeting the E domain of ER-␣ to the cell membrane (but not to the nucleus), suggesting the role of the plasma membrane ER in this cell action. ERK activation by E 2 also underlies the stimulation of nitric oxide production in endothelial cells (ECs) and prevents glutaminergic, excitotoxicity-induced neuronal necrosis (72) . Augmentation of ERK may also induce the activation of immediate early genes such as c-fos (84), which then transactivate other genes that are important for the cell biological effects of this steroid.
Signaling may also more directly activate E 2 -responsive target genes. For instance, E 2 -induced prolactin gene transcription requires signaling through ERK (85) . By activating kinases, the membrane ER can participate in a transactivation function that was felt to be the exclusive domain of the nuclear ER (18, 21) . A similar scenario has been established for a variety of growth factors that activate ERK and thus phosphorylate the nuclear ER for instance at serine 118 (5). ERK-induced phosphorylation stimulates the transactivation function of ER in an E 2 -independent fashion (25) . It has also been shown that nuclear receptor coactivator proteins can be phosphorylated by ERK and that this enhances steroid receptor transcriptional functions (66) . These different substrates for phosphorylation by ERK may in part contribute to the important cross talk between growth factor receptor tyrosine kinases, such as the epidermal growth factor receptor, and ERs in target cells (12) , including breast cancer cells. Regulation by signaling from the membrane also extends to the repression of genes. E 2 suppresses the activator protein 1-mediated transactivation of the preproendothelin-1 gene, induced by angiotensin II via ERK signaling in ECs (47) .
Additional signal transduction pathways originating from the membrane have recently been identified as being rapidly responsive to E 2 . In ECs, this sex steroid (as well as glucocorticoid and thyroid hormone) stimulates phosphoinositol-3-hydroxy kinase (71) . This leads to the activation of Akt kinase and the generation of nitric oxide and is inhibited by ICI-182780. In an in vivo model of muscle injury following ischemia-reperfusion, this pathway was responsible for the ability of E 2 to prevent leukocyte accumulation (71) . Also in ECs, E 2 activates the p38␤ isoform of the MAP kinase family, leading to activation of the threonine/serine MAPKAP-2 kinase and the phosphorylation of heat shock protein 27 (HSP27) (65) . By expressing dominant-negative mutants of these three molecules, E 2 was shown to utilize this pathway to protect ECs from metabolic disruption of the actin cytoskeleton and hypoxia-induced cell death and to stimulate angiogenesis.
In ER-expressing CHO cells, it was also demonstrated that E 2 activates a third MAP kinase, c-Jun NH 2 -terminal kinase (JNK), via ER-␤ but inhibits this kinase via ER-␣ (63). These results indicate that the two subtypes of ER can differentially modulate signaling pathways. The physiological relevance of this observation was recently demonstrated in breast cancer cells. Both chemotherapy and radiation treatment kill cells mainly by inducing apoptosis via a JNK-dependent mechanism. It has recently been shown that E 2 rapidly blocks JNK activation in this setting, preventing the JNK-induced, inactivating phosphorylation of Bcl-2 and Bcl-xl proteins, the subsequent stimulation of the caspase cascade, and cell death (64) . In this way, E 2 can act as a survival factor, initiated through membrane signaling. Interestingly, tamoxifen, an estrogen antagonist that prevents the primary occurrence or recurrence of breast cancer in women, activates apoptosis of breast cancer cells through a JNK-dependent mechanism (39) . With regard to the regulation of JNK activity, the ability of E 2 to prevent osteoclast formation in bone stems from the inhibition of regulating receptor activation of NF-B ligand-induced JNK activation. This is likely to occur from a membrane ER expressed on monocytes (74) .
Localization of membrane ER. To better understand the function of the membrane ER, we need to know the physical structure of the receptor and where it resides within the lipid bilayer. The endogenous receptor has not yet been isolated and sequenced. However, we know that a variety of antibodies directed against multiple epitopes of the nuclear ER-␣ identify an endogenous membrane protein in several cell types (53) . In addition, expression in CHO cells of a single cDNA for ER-␣ results in both membrane and nuclear pools of receptors (63) . Therefore, it appears that the membrane receptor must be very similar to the nuclear receptor. Recent work has begun to clarify the location of this receptor within the plasma membrane. Signaling by growth factor receptors and non-growth factor tyrosine kinases as well as G protein receptors occurs at least in part after localization to plasma membrane microstructures, known as caveolae (1) . This organelle facilitates signal transduction through the localization of signaling molecules (51) , and this interaction is dependent on the high-cholesterol content and a structural coat protein family, the caveolins. It is believed that caveolin-1 can serve as a scaffold protein, associating with a variety of signaling molecules to organize their activation within the caveolae domains. Although caveolin indirectly facilitates signaling, it may directly inhibit various signal molecules. It is appreciated that caveolin-1 physically associates with endothelial nitric oxide synthase (eNOS). After calcium activation, calmodulin competitively displaces caveolin-1 from binding to eNOS (15) and caveolin-1 moves out of the membrane (26) . These events are necessary for the activation of eNOS. Recently, ER has been shown to localize mainly to caveolae but also to noncaveolar fractions of the EC plasma membrane (7, 26) . It is primarily within caveolae that E 2 activates eNOS after E 2 -ER binding (7) . We recently found that caveolin-1 physically associates with ERs in several cell compartments and that caveolin may impact the ability of ERs to both signal and localize to the plasma membrane (Razandi M, Pedram A, and Levin ER, unpublished observations).
Complementary role of membrane and nuclear ER. Although ERs in the membrane and nuclear compartments appear to act by very different mechanisms (signaling vs. transcriptional transactivation), the cell biological roles may overlap or be complementary. As mentioned, there is precedent for E 2 to activate gene transcription from both receptor pools. One may envision that kinase signaling can rapidly activate transcription, which can then be sustained by the nuclear receptor. As mentioned, the latter's action is probably facilitated by the phosphorylation of coactivator proteins, and this could result from ER signaling from the membrane. Signaling from the membrane may also amplify the actions of the nuclear receptor. Furthermore, signaling appears to play an important role in the posttranslational modification of proteins that can be upregulated in their synthesis via the nuclear receptor.
One example of this is the important anti-apoptotic protein, Bcl-2. It is well described that this gene can be activated by E 2 , in part through an Sp-1 site contained within the Bcl-2 promoter (59). Moreover, it has recently been shown that the survival function of Bcl-2 can be downregulated by phosphorylation within the "loop domain" of the protein (73) . E 2 has been shown to prevent the inactivating phosphorylation of this protein by JNK, thereby enhancing breast cancer cell survival (64) . Thus the activity and concentrations of this protein are modified by discrete cellular pools of ERs; this allows both rapid and prolonged regulation of this important protein. Another example is the HSP27. Along with other family members, this protein is known to associate with ERs, especially in breast cancer (87) . The HSP27 gene is an acknowledged target for nuclear ER transcriptional upregulation (60) . Recently, it has been shown that the modulation of HSP27 phosphorylation occurs in response to E 2 acting at membrane ER and that this is critical to the actions of E 2 in ECs (65) . Again, the membrane and nuclear pools of ERs have different but complementary actions to regulate the short and longer term cell biological consequences of HSP27 function.
Mechanisms of signaling from the membrane. How does the membrane ER signal? If we assume that the structure of this protein is very similar to the nuclear receptor protein, there does not appear to be a catalytic or kinase domain present. However, E 2 can activate a variety of signaling events, many of which functionally link to activation of G-protein-effected pathways (27, 35) . For instance, E 2 rapidly activates membrane adenylate cyclase (2, 57) (often a G s ␣ function), whereas IP 3 generation and intracellular calcium increases are noted in a variety of cell types (34) (often a G q ␣ or G␤␥ function). Direct evidence that ERs can activate several G protein ␣-subunits and the resulting signaling comes from CHO cell membranes expressing either ER-␣ or ER-␤ (63). Here, IP 3 and cAMP are rapidly Fig. 2 . Schema of E2 signaling from the membrane in breast cancer. The putative membrane ER activates extracellular-regulated kinase (ERK), via HB-EGF and EGF receptor (EGFR) transactivation, which then signals to cell proliferation. This same pathway contributes to cell survival. The membrane ER also inhibits stress-induced c-Jun NH2-terminal kinase (JNK) activation, importantly contributing to anti-apoptosis. GF, growth factor; MEK, mitogen-activated protein kinase kinase. generated in response to E 2 , associated with the activation of G s and G q ␣. Evidence of direct G protein activation in cells expressing endogenous ER, however, has not yet been shown. Because both G proteins and ERs exist in caveolae, it is likely that an interaction may take place within this membrane domain. Alternatively, it has recently been reported, at least in MCF-7 breast cancer cells expressing endogenous ER, that E 2 can activate a membrane orphan GPCR, GPR30 (16) . This was reported to lead to the activation of ERK. Curiously, these events were reported to occur independently of ER, through an undefined mechanism. Many GPCRs have been shown to activate ERK in some cell types through the generation of heparinbinding EGF and the subsequent activation and signaling by the EGF receptor (61) . This may contribute to the ability of E 2 to activate ERK, especially in MCF-7 cells (16), and would provide an additional cross-talk mechanism for the observed interdependence of ER and EGF receptor in modulating uterine and breast cancer cell biology (12) . E 2 -ER may also utilize other growth factor receptors for signal transduction. In cells expressing cotransfected ER and the insulin-like growth factor (IGF)-1 receptor, E 2 causes the phosphorylation of IGF-1 receptor and enhanced activation of ERK. The two receptors were found to physically associate in this model, as well (24) . These interactions may be particularly relevant to breast cancer, since E 2 has been shown to augment the ability of IGF-1 to induce cell proliferation (13) , and this may be mediated through insulin receptor substrate-1 upregulation (33). However, in nude mice, MCF-7 cells proliferated despite IGF-1 receptor blockade (3). Also, IGF-1 may phosphorylate and thus activate the nuclear ER to induce transcription (24) . There is also evidence that, in autocrine fashion, E 2 can upregulate PC-cell-derived growth factor production from MCF-7 cells (37), although this may result from nuclear ER action. This growth factor had a part in mediating the ability of E 2 to stimulate DNA synthesis in these cells. E 2 may facilitate sex hormone binding globulin signaling from a putative sex hormone binding globulin membrane receptor in prostate cells by an undefined interaction (49) . Finally, when both estrogen and androgen receptors are expressed in the same cell, a complex of signaling molecules including both receptors results from ligation by either estrogen or androgen (46) . This may serve the purpose of augmenting signal transduction, beyond that which can be activated in response to either sex steroid alone (45) .
The importance of the membrane ER might be intuited from recent discoveries in plants. Arabidopsis and other flowering plants produce brassinosteroids, compounds that regulate growth and fertility, and share the basic four phenolic ring structure with E 2 . There are no nuclear receptors that have been discovered for these plant steroids. However, a transmembrane receptor tyrosine kinase has been found to mediate the binding and signaling of brassinosteroids to cell biology (83) . Thus steroid action at the plasma membrane is an ancient and highly conserved function, suggesting its great importance.
FUTURE RESEARCH DIRECTIONS
It is now appreciated that there are multiple pools of endogenous ER expressed in a wide variety of target cells for E 2 action. In fact, an important direction for ER research will be to define the potential roles of the poorly understood cytosolic-localized ER. As an antiapoptotic factor, cytosolic E 2 -ER complexes may locally regulate mitochondrial membrane potential, In support of this idea, it has been shown that E 2 can modulate mitochondrial enzymes (88) . It will also be necessary to continue to define rapid, nongenomic actions of E 2 at the membrane receptor, establishing new signal transduction pathways for this receptor, and to learn their impact on cell biology (Fig. 2) .
The complementary functions of both membrane and nuclear ERs will best be defined when specific reagents become available to activate or antagonize one receptor but not the other. We also need to understand the unique and overlapping functions of E 2 mediated through ER-␣ and ER-␤, particularly defining the results of heterodimerization in cells expressing both receptors. This is likely to be relevant to both the nongenomic and genomic actions of the sex steroid. Details of how the nuclear receptor organizes the transcriptional apparatus to induce genes and how E 2 /ER modulates histone and chromatin will be (and currently is) a topic of much investigation. Equally important is the need to know the structure of the membrane receptor, to understand how it translocates to discrete domains within the membrane, and to understand how it precisely induces signal transduction. It is hoped that by modulating the function of discrete cellular pools of ER with specific agonists/antagonists, we might be able to avoid the unwanted effects of this sex steroid (venous thrombosis, breast cancer promotion, and so forth) but accrue the desirable cardiovascular, bone, and perhaps central nervous system actions of estradiol.
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